Publications by authors named "Dominique Seret-Begue"
Article Synopsis
- The study aimed to determine if diabetes is a risk factor for severe COVID-19 outcomes, independent of age and other health conditions, as diabetes is often seen in older individuals.
- Conducted as part of the CORONADO initiative, the research matched 2210 COVID-19 patients with and without diabetes by age, sex, and admission date, assessing outcomes like death and the need for invasive mechanical ventilation.
- Results showed that diabetes patients had higher rates of adverse outcomes within both 7 and 28 days of hospital admission, indicating that diabetes is a significant risk factor for severe COVID-19 complications regardless of age and comorbidity.
Article Synopsis
- This study examined how having metabolic and bariatric surgery (MBS) affects the outcomes of patients with type 2 diabetes (T2D) and severe obesity who are hospitalized for COVID-19.
- Researchers matched patients with a history of MBS to those without, focusing on their age, sex, and BMI at the time of either surgery or COVID-19 admission.
- Results showed that patients with MBS had significantly lower rates of invasive mechanical ventilation or death within 7 and 28 days following admission compared to those without MBS, suggesting better COVID-19 prognosis for MBS patients.
Article Synopsis
- The study examined sex differences in severe outcomes of COVID-19 among adults with diabetes, analyzing data from 2,380 hospitalized patients.
- Findings revealed that females had a lower risk of invasive mechanical ventilation, death, and ICU admission compared to males, although this female advantage was less evident in overall in-hospital mortality.
- The research highlighted specific predictors of death linked to sex, emphasizing the need for tailored COVID-19 management strategies based on biological differences.
Article Synopsis
- The CORONADO study examines outcomes in diabetic patients hospitalized due to COVID-19, focusing on hospital discharge and death rates within 28 days of admission.
- The study analyzed data from 2,796 patients, revealing that 50.2% were discharged and 20.6% died; factors influencing discharge included younger age and metformin use, while complications and severity indicators were linked to a higher risk of death.
- The findings aim to identify key prognostic factors to guide clinical decision-making for diabetic patients during the pandemic.
Article Synopsis
- The study aimed to investigate the effects of prior metformin use on the health outcomes of type 2 diabetes patients hospitalized for COVID-19.
- An analysis of 2,449 patients showed that metformin users generally had better survival rates and lower mortality compared to non-users, particularly noted at days 7 and 28 after admission.
- The conclusion suggests that metformin may reduce the risk of death in diabetes patients with COVID-19, indicating its potential beneficial effects during hospitalization.
Article Synopsis
- * Analysis was conducted on 1,965 patients from the CORONADO study, categorizing them into normal weight, overweight, and various obesity classes, revealing significant risks associated with higher BMI for intubation and death by day 7.
- * The findings suggest that while overweight and obesity worsen early COVID-19 prognosis in T2D patients, this negative effect is not observed in patients aged 75 and older, indicating a need for tailored management strategies for older adults.
Background: Riedel's thyroiditis (RT) is a rare disease characterized by a chronic inflammatory lesion of the thyroid gland with invasion by a dense fibrosis. Publications of the imaging features of RT are scarce. To our knowledge, ultrasound elastography (USE) findings have not been previously reported.
View Article and Find Full Text PDF